MEDICAL TECHNOLOGY DEPARTMENT

NOTRE DAME OF MARBEL UNIVERSITY

City of Koronadal, South Cotabato
Telephone No.: (+63 83) 228 2218; 228 2377 loc 129 Email Address: medtech@ndmu.edu.ph
Facebook: @ndmumtdept www.ndmu.edu.ph

Indonesian Halal Pharmaceutical: Challenges and Market Opportunities Yedi

Herdiana, Taofik Rusdiana2
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy,
Universitas Padjadjaran, Sumedang 45363, Indonesia
Critic by: Joe-Ali G. Manampan

The article "Indonesian Halal Pharmaceutical: Challenges and Market Opportunities"

by Yedi Herdiana and Taofik Rusdiana provides a good overview of the halal pharmaceutical
market in Indonesia. The authors discuss the challenges and opportunities facing the
Indonesian halal pharmaceutical industry, as well as the potential for growth in this market.
The article does a good job of highlighting the key challenges facing the Indonesian halal
pharmaceutical industry. These challenges include: A lack of awareness of halal
pharmaceuticals among consumers, a lack of standardization in halal certification, the high
cost of halal certification, and competition from imported halal pharmaceuticals

The authors also discuss the opportunities for growth in the Indonesian halal
pharmaceutical market. These opportunities include: The growing Muslim population in
Indonesia, the increasing disposable incomes of Muslims, and the growing awareness of halal
products among non-Muslims. The article could be improved by providing more information
on the following: The specific regulatory challenges facing the Indonesian halal
pharmaceutical industry, the role of the government in supporting the growth of the halal
pharmaceutical industry, and the potential for the Indonesian halal pharmaceutical industry to
export products to other Muslim-majority countries

The article does not address the potential for conflict between halal certification and
intellectual property rights. For example, a company that develops a new pharmaceutical
product may be able to obtain a patent on that product. However, if the product is not halal, it
may not be able to be sold in the halal market. This could create a conflict between the
company's intellectual property rights and the religious beliefs of consumers. The article does
not discuss the potential for the halal pharmaceutical market to be used for greenwashing.
Greenwashing is a marketing tactic in which companies make false or misleading claims
about the environmental benefits of their products. In the case of halal pharmaceuticals,
companies could make claims about the ethical or sustainable nature of their products, even if
these claims are not based on evidence.

The article does not address the potential for the halal pharmaceutical market to be
used for religious discrimination. For example, a company that manufactures halal
pharmaceuticals could refuse to hire or promote employees who are not Muslim. This could
be seen as a form of religious discrimination. The article does not adequately address the
issue of animal testing in the development of halal pharmaceuticals. While the article
mentions that halal pharmaceuticals must not be tested on animals that have been forbidden
for consumption in Islam, it does not discuss the ethical implications of animal testing in
general.
 MEDICAL TECHNOLOGY DEPARTMENT
NOTRE DAME OF MARBEL UNIVERSITY
City of Koronadal, South Cotabato
Telephone No.: (+63 83) 228 2218; 228 2377 loc 129 Email Address: medtech@ndmu.edu.ph
Facebook: @ndmumtdept www.ndmu.edu.ph

Animal testing is a controversial issue, and there is a growing movement to ban or

restrict animal testing in the development of pharmaceuticals. Some Muslims may object to
the use of animal testing in the development of halal pharmaceuticals, even if the animals are
not forbidden for consumption.

The article could be improved by providing a more nuanced discussion of the issue of
animal testing in the development of halal pharmaceuticals. The authors could discuss the
different perspectives on animal testing among Muslims, and they could explore the potential
for developing halal pharmaceuticals without the use of animal testing.

The halal pharmaceutical market is a growing one with significant potential for
growth. However, in order to realize this potential, the industry must address a number of
challenges. These challenges include a lack of awareness of halal pharmaceuticals among
consumers, a lack of standardization in halal certification, the high cost of halal certification,
and competition from imported halal pharmaceuticals.

The government can play a role in supporting the growth of the halal pharmaceutical
industry by providing funding for research and development, developing halal certification
standards, and promoting halal pharmaceuticals to consumers. The industry can also address
the challenges it faces by educating consumers about halal pharmaceuticals, developing more
affordable halal certification processes, and focusing on innovation.

By addressing these challenges, the Indonesian halal pharmaceutical industry can

position itself as a leader in the global halal pharmaceutical market.